These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 18328541

  • 21. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
    Khorana AA.
    Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
    Nutescu EA, Wittkowsky AK, Dobesh PP, Hawkins DW, Dager WE.
    Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Venous thromboembolism prevention in patients with heart failure: an often neglected issue.
    Imberti D, Pierfranceschi MG, Falciani M, Prisco D.
    Pathophysiol Haemost Thromb; 2008 Sep; 36(2):69-74. PubMed ID: 19127085
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Venous thromboembolism in cancer patients undergoing major surgery.
    Osborne NH, Wakefield TW, Henke PK.
    Ann Surg Oncol; 2008 Dec; 15(12):3567-78. PubMed ID: 18841419
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.
    Nutescu EA, Spinler SA, Wittkowsky A, Dager WE.
    Ann Pharmacother; 2009 Jun; 43(6):1064-83. PubMed ID: 19458109
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Venous thromboembolism risk and antithrombotic prophylaxis among patients admitted to Spanish hospitals (ENDORSE study)].
    Nieto Rodríguez JA, ENDORSE.
    Med Clin (Barc); 2009 Jun 06; 133(1):1-7. PubMed ID: 19446302
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients.
    Gussoni G, Foglia E, Frasson S, Casartelli L, Campanini M, Bonfanti M, Colombo F, Porazzi E, Ageno W, Vescovo G, Mazzone A, FADOI Permanent Study Group on Clinical Governance.
    Thromb Res; 2013 Jan 06; 131(1):17-23. PubMed ID: 23141845
    [Abstract] [Full Text] [Related]

  • 35. [Results of ENDORSE study in Hungary. Multinational, cross-sectional study to assess the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting].
    Losonczy H, Tar A, ENDORSE magyar vizsgálói.
    Orv Hetil; 2008 Nov 02; 149(44):2069-76. PubMed ID: 18952526
    [Abstract] [Full Text] [Related]

  • 36. Prevention of venous thromboembolism after surgery.
    Michota FA.
    Cleve Clin J Med; 2009 Nov 02; 76 Suppl 4():S45-52. PubMed ID: 19880836
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH.
    Clin Ther; 2008 Sep 02; 30(9):1726-36. PubMed ID: 18840379
    [Abstract] [Full Text] [Related]

  • 40. Low-molecular-weight heparin use in the obese, elderly, and in renal insufficiency.
    Clark NP.
    Thromb Res; 2008 Sep 02; 123 Suppl 1():S58-61. PubMed ID: 18809206
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.